Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Feb;32(2):193-8.
doi: 10.1007/s11745-997-0024-1.

Phospholipid fatty acid composition in type I and type II rat muscle

Affiliations

Phospholipid fatty acid composition in type I and type II rat muscle

W G Blackard et al. Lipids. 1997 Feb.

Abstract

The fatty acid composition of the membrane phospholipids phosphatidylcholine (PC) and phosphatidylethanolamine in insulin-sensitive Type I (soleus) and insulin-resistant Type II (EDL) muscle is not known. In the present studies, soleus and EDL muscles were removed from 250-300 g Sprague-Dawley rats, and the fatty acid composition of total and individual phospholipid (PL) species was quantitated. As expected, triglyceride content was increased twofold in soleus muscle. No quantitative differences in the individual PL species or cholesterol content were found between the two muscles. However, a striking difference in PL fatty acid composition was observed in the PC fraction. An increase in 16:0 with decreases in 18:0, 18:1, 22:5n-3, and 22:6n-3 (P < 0.001 for each) was observed in the PC fraction of EDL compared to that from soleus, consistent with reduced elongation of PC fatty acids. Inhibition of fatty acid oxidation with the carnitine palmitoyl transferase-1 inhibitor, etomoxir, did not alter the fatty acid pattern in either muscle. We conclude that an alteration in PL fatty acid composition consistent with reduced elongation of both saturated and unsaturated fatty acids is observed in Type II muscle. The restriction of these alterations to the PC fraction has important implications.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Diabetes. 1981 Aug;30(8):702-4 - PubMed
    1. Scand J Clin Lab Invest. 1988 Sep;48(5):381-8 - PubMed
    1. Diabetes. 1991 Feb;40(2):280-9 - PubMed
    1. J Biol Chem. 1986 Nov 15;261(32):14939-44 - PubMed
    1. J Clin Invest. 1995 Dec;96(6):2802-8 - PubMed

Publication types

LinkOut - more resources